BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11432152)

  • 1. The Academy of Managed Care Pharmacy's format for formulary submission.
    Penna P
    Manag Care Interface; 2001 Jun; 14(6):61-2. PubMed ID: 11432152
    [No Abstract]   [Full Text] [Related]  

  • 2. Formulary submission process catches on ... slowly.
    Cross M
    Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
    [No Abstract]   [Full Text] [Related]  

  • 3. Showing outcomes and proving value brings success.
    Fullerton DS; Atherly D; Sullivan SD
    Manag Care Interface; 2001 Jun; 14(6):63-5, 71. PubMed ID: 11432153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raising the bar in the formulary decision process.
    Navarro RP
    Manag Care Interface; 1999 Jul; 12(7):51, 54. PubMed ID: 10539501
    [No Abstract]   [Full Text] [Related]  

  • 5. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN; Avey SG; Sullivan SD
    Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drug formulary decision-making process.
    Brehany J; Cohen P; Sax MJ
    Healthplan; 1999; 40(3):85-92. PubMed ID: 10538088
    [No Abstract]   [Full Text] [Related]  

  • 7. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Academy of Managed Care Pharmacy's concepts in managed care pharmacy: prior authorization and the formulary exception process.
    Fallik B
    J Manag Care Pharm; 2005 May; 11(4):358-61. PubMed ID: 15871651
    [No Abstract]   [Full Text] [Related]  

  • 10. Manufacturer response to AMCP Format dossier requests.
    Lyles A; Watkins JD
    J Manag Care Pharm; 2007 Apr; 13(3):290-1; author reply 291-2. PubMed ID: 17407398
    [No Abstract]   [Full Text] [Related]  

  • 11. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulary decision-making considerations: COX-2 inhibitors.
    Shaya FT; Wong W; Shin JY; Martin L; Samant N
    Manag Care Interface; 2004 Nov; 17(11):29-36, 41. PubMed ID: 15573802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding, creating, and working with formulary systems.
    Quinn CE; Barisano A
    Am J Manag Care; 1999 Oct; 5(10):1311-7; quiz 1318-9. PubMed ID: 10622996
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of the P&T committee: enhancing the health technology assessment process.
    Tadlock C
    Manag Care Interface; 2006 Feb; 19(2):14-5. PubMed ID: 16529077
    [No Abstract]   [Full Text] [Related]  

  • 17. The economics of lipid management.
    Mullins CD
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-based decision making in managed care pharmacy.
    Penna P
    Manag Care Interface; 2002 May; 15(5):43-4. PubMed ID: 12024870
    [No Abstract]   [Full Text] [Related]  

  • 19. The bleeding edge of decision making in managed health care--Kaiser-Permanente's model for formulary development.
    Campen D
    Value Health; 2002; 5(5):383-9. PubMed ID: 12201855
    [No Abstract]   [Full Text] [Related]  

  • 20. Providing health economic data to managed care.
    Navarro RP
    Manag Care Interface; 1998 Sep; 11(9):62-3, 66. PubMed ID: 10187588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.